Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
316-330 of 474
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Kathleen N. Moore, MD
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Kathleen N. Moore, MD
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Ryan Quigley
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Project Oncology®From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Ryan Quigley
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Project Oncology®Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Brian Slomovitz, MD
- advertisement
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Project Oncology®Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Brian Slomovitz, MD
Putting Patients First: Personalized Care in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerPutting Patients First: Personalized Care in Metastatic Breast Cancer
Ashley Baker, MSN, PMHNP
Giancarlo Moscol, M.D.
DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
Marlene Mimi Maeusli, PhD.
Clinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
On the Frontlines of Metastatic Breast CancerClinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
Ashley Baker, MSN, PMHNP
Giancarlo Moscol, M.D.
- advertisement
Improving Metastatic Breast Cancer Care Through Integrated Palliative Support
On the Frontlines of Metastatic Breast CancerImproving Metastatic Breast Cancer Care Through Integrated Palliative Support
Ryan Quigley
Diagnosing LCNEC of the Lung: Challenges and Strategies
Project Oncology®Diagnosing LCNEC of the Lung: Challenges and Strategies
Junaid Arshad, MD, MS
Personalizing Care for Large Cell Neuroendocrine Carcinoma
Project Oncology®Personalizing Care for Large Cell Neuroendocrine Carcinoma
Junaid Arshad, MD, MS
